Skip to search formSkip to main contentSkip to account menu

borrelidin

Known as: 2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl)-cyclopentanecar boxylic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
4,352,803 10/1982 Matsumoto et al................. 544/363 4,455,310 6/1984 Sakamoto et al. .................. 544/363 4,544,658… 
2017
2017
OF THE DISCLOSURE Polyepoxides may be cured to an insoluble, infusible product by reacting a polyepoxide containing more than one… 
2014
2014
Institut für Organische Chemie, Leibniz U 30167 Hannover, Germany. E-mail: frank.h 762-3011; Tel: +49 511-762-4603 Department of… 
2011
2011
Objective To evaluate the effect of Borrelidin on the apoptosis of splenic sinus endothelial cells and to provide new drugs to… 
2010
2010
Borrelidin, an antibiotic found to be an angiogenesis inhibitor, is a potential drug candidate due to its antiangiogenic activity… 
2008
2008
S OF COMMUNICATIONS AND POSTERS About 400 Czechoslovak microbiologists participated in the 18th Congress of the Czechoslovak… 
2007
2007
The present invention relates to derivatives of borrelidin that are useful in medicine, e.g. in the treatment of cancer or B-cell… 
1966
1966
Structure II has been determined for the antibiotic Borrelidin by chemical degradation, mass spectroscopy and NMR-spectroscopy of…